Literature DB >> 23456319

Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.

Akira Haro1, Tokujiro Yano, Mikihiro Kohno, Tsukihisa Yoshida, Takaomi Koga, Tatsuro Okamoto, Mitsuhiro Takenoyama, Yoshihiko Maehara.   

Abstract

BACKGROUND: The clinical significance of Brachyury expression and its relationship to epithelial-mesenchymal transition in primary lung carcinoma is unclear.
METHODS: Expression of Brachyury mRNA was investigated in 104 surgically resected primary lung carcinoma tissues. Immunohistochemical analysis of Brachyury transcription factor, Slug, E-cadherin, IL-8, N-cadherin, and Ki67 was performed in 67 of 104 cases, and their expression was correlated to prognoses and clinicopathological factors.
RESULTS: Brachyury mRNA expression in primary lung carcinoma tissues was a significant predictor of poor prognosis for 5-year disease-free survival and overall survival rates and was significantly correlated to vascular invasion, lymphatic permeation, histological grade, pathologic T stage, and pathologic N stage (P < 0.05). Brachyury mRNA expression was significantly inversely correlated to E-cadherin expression (P = 0.0252) and positively correlated to IL-8 protein (P = 0.0241) and to Slug protein (P = 0.0243) in adenocarcinoma tissues.
CONCLUSIONS: A positive association between Brachyury and Slug and IL-8, and a negative association with E-cadherin may lead to invasiveness and metastasis in primary lung carcinoma. Brachyury mRNA expression is a significant predictor of poor prognosis in primary lung carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456319     DOI: 10.1245/s10434-013-2914-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  26 in total

1.  Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors.

Authors:  Julie M Collins; Renee N Donahue; Yo-Ting Tsai; Michell Manu; Claudia Palena; Margaret E Gatti-Mays; Jennifer L Marté; Ravi A Madan; Fatima Karzai; Christopher R Heery; Julius Strauss; Houssein Abdul-Sater; Lisa Cordes; Jeffrey Schlom; James L Gulley; Marijo Bilusic
Journal:  Oncologist       Date:  2019-12-26

2.  The embryonic Brachyury transcription factor is a novel biomarker of GIST aggressiveness and poor survival.

Authors:  Filipe Pinto; Nathalia C Campanella; Lucas F Abrahão-Machado; Cristovam Scapulatempo-Neto; Antonio T de Oliveira; Maria J Brito; Raquel P Andrade; Denise P Guimarães; Rui M Reis
Journal:  Gastric Cancer       Date:  2015-05-21       Impact factor: 7.370

3.  Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.

Authors:  Jo A Tucker; Caroline Jochems; Benjamin Boyerinas; Jonathan Fallon; John W Greiner; Claudia Palena; Timothy C Rodell; Jeffrey Schlom; Kwong-Yok Tsang
Journal:  Cancer Immunol Immunother       Date:  2014-09-04       Impact factor: 6.968

4.  Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.

Authors:  Duane H Hamilton; Mario Roselli; Claudia Palena; Fiorella Guadagni; Patrizia Ferroni; Leopoldo Costarelli; Francesco Cavaliere; Mariateresa Taffuri
Journal:  Endocr Relat Cancer       Date:  2016-10       Impact factor: 5.678

Review 5.  Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition.

Authors:  Duane H Hamilton; Justin M David; Charli Dominguez; Claudia Palena
Journal:  Cells Tissues Organs       Date:  2017-02-20       Impact factor: 2.481

6.  T-box transcription factor Brachyury in lung cancer cells inhibits macrophage infiltration by suppressing CCL2 and CCL4 chemokines.

Authors:  Su Chen; Jian Jiao; Dongjie Jiang; Zongmiao Wan; Lei Li; Ke Li; Leqin Xu; Zhenhua Zhou; Wei Xu; Jianru Xiao
Journal:  Tumour Biol       Date:  2015-03-06

7.  Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.

Authors:  Zhiwei Zhao; Shichao Wang; Yingbo Lin; Yali Miao; Ye Zeng; Yongmei Nie; Peng Guo; Guangyao Jiang; Jiang Wu
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

8.  Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.

Authors:  Christopher R Heery; B Harpreet Singh; Myrna Rauckhorst; Jennifer L Marté; Renee N Donahue; Italia Grenga; Timothy C Rodell; William Dahut; Philip M Arlen; Ravi A Madan; Jeffrey Schlom; James L Gulley
Journal:  Cancer Immunol Res       Date:  2015-06-30       Impact factor: 11.151

9.  Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.

Authors:  Markku Miettinen; Zengfeng Wang; Jerzy Lasota; Christopher Heery; Jeffrey Schlom; Claudia Palena
Journal:  Am J Surg Pathol       Date:  2015-10       Impact factor: 6.394

10.  Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury.

Authors:  Christopher R Heery; Claudia Palena; Sheri McMahon; Renee N Donahue; Lauren M Lepone; Italia Grenga; Ulrike Dirmeier; Lisa Cordes; Jenn Marté; William Dahut; Harpreet Singh; Ravi A Madan; Romaine I Fernando; Duane H Hamilton; Jeffrey Schlom; James L Gulley
Journal:  Clin Cancer Res       Date:  2017-08-30       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.